Breaking News

New Dengue Vaccine Gains First Latin America Approval

May 11, 2023 • 7:29 am CDT
ECDC dengue map May 2023
(Precision Vaccinations News)

Takeda today announced its dengue vaccine QDENGA® had received several approvals, including one by Brazil's National Health Surveillance Agency in March 2023 for use in individuals between 4 years and 60 years to protect against all four serotypes.

Brazil's approval marks the first approval of QDENGA in Latin America, where dengue is endemic in various countries.

Recently, Costa Rica confirmed a unique dengue outbreak.

QDENGA is the only dengue vaccine approved for use regardless of previous exposure and without needing pre-vaccination testing.

Takeda's press release on May 11, 2023, confirmed it continues progressing with additional regulatory filings, such as the U.S.

The U.S. CDC published provisional data as of May 5, 2023, indicating the U.S. States, led by Florida, have reported 98 dengue cases in 2023, and U.S. Territories have confirmed 238 dengue cases this year.

Our Trust Standards: Medical Advisory Committee

Share